Validation of 3‐ and 5‐point severity scales to assess ARIA‐E

por Bracoud, Luc, Klein, Gregory, Lyons, Marco, Scelsi, Marzia A., Wojtowicz, Jakub, Bullain, Szofia, Purcell, Derk, Fiebach, Jochen B., Barakos, Jerome, Suhy, Joyce
Publicado 2023

Comparing ARIA‐E severity scales and effects of treatment management thresholds

por Klein, Gregory, Scelsi, Marzia A., Barakos, Jerome, Fiebach, Jochen B., Bracoud, Luc, Suhy, Joyce, Delmar, Paul, Lyons, Marco, Wojtowicz, Jakub, Bullain, Szofia, Barkhof, Frederik, Purcell, Derk
Publicado 2022

Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease

por Salloway, Stephen, Chalkias, Spyros, Barkhof, Frederik, Burkett, Patrick, Barakos, Jerome, Purcell, Derk, Suhy, Joyce, Forrestal, Fiona, Tian, Ying, Umans, Kimberly, Wang, Guanfang, Singhal, Priya, Budd Haeberlein, Samantha, Smirnakis, Karen
Publicado 2021

The value of subtraction MRI in detection of amyloid-related imaging abnormalities with oedema or effusion in Alzheimer’s patients: An interobserver study

por Martens, Roland M., Bechten, Arianne, Ingala, Silvia, van Schijndel, Ronald A., Machado, Vania B., de Jong, Marcus C., Sanchez, Esther, Purcell, Derk, Arrighi, Michael H., Brashear, Robert H., Wattjes, Mike P., Barkhof, Frederik
Publicado 2017

Development, initial validation, and application of a visual read method for [(18)F]MK‐6240 tau PET

por Shuping, Joanna L., Matthews, Dawn C., Adamczuk, Katarzyna, Scott, David, Rowe, Christopher C., Kreisl, William C., Johnson, Sterling C., Lukic, Ana S., Johnson, Keith A., Rosa‐Neto, Pedro, Andrews, Randolph D., Van Laere, Koen, Cordes, Lindsay, Ward, Larry, Wilde, Claire L., Barakos, Jerome, Purcell, Derk D., Devanand, Davangere P., Stern, Yaakov, Luchsinger, Jose A., Sur, Cyrille, Price, Julie C., Brickman, Adam M., Klunk, William E., Boxer, Adam L., Mathotaarachchi, Sulantha S., Lao, Patrick J., Evelhoch, Jeffrey L.
Publicado 2023